Two Sigma Investments’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-660,601
| Closed | -$2.71M | – | 3146 |
|
|
2022
Q1 | $2.71M | Buy |
660,601
+192,946
| +41% | +$700K | 0.01% | 1198 |
|
|
2021
Q4 | $1.67M | Sell |
467,655
-626,855
| -57% | -$2.19M | ﹤0.01% | 2088 |
|
|
2021
Q3 | $3.98M | Sell |
1,094,510
-235,335
| -18% | -$951K | 0.01% | 1406 |
|
|
2021
Q2 | $5.8M | Sell |
1,329,845
-54,282
| -4% | -$221K | 0.01% | 1112 |
|
|
2021
Q1 | $5.69M | Buy |
1,384,127
+306,974
| +28% | +$1.33M | 0.01% | 965 |
|
|
2020
Q4 | $4.3M | Sell |
1,077,153
-57,823
| -5% | -$187K | 0.01% | 1022 |
|
|
2020
Q3 | $3.06M | Sell |
1,134,976
-142,094
| -11% | -$393K | 0.01% | 1057 |
|
|
2020
Q2 | $3.51M | Sell |
1,277,070
-231,406
| -15% | -$646K | 0.02% | 818 |
|
|
2020
Q1 | $3.56M | Sell |
1,508,476
-477,559
| -24% | -$1.62M | 0.03% | 660 |
|
|
2019
Q4 | $9.33M | Buy |
1,986,035
+1,712,989
| +627% | +$7.01M | 0.03% | 648 |
|
|
2019
Q3 | $913K | Sell |
273,046
-244,967
| -47% | -$807K | ﹤0.01% | 2069 |
|
|
2019
Q2 | $1.7M | Sell |
518,013
-173,280
| -25% | -$501K | 0.01% | 1549 |
|
|
2019
Q1 | $2.1M | Buy |
691,293
+75,831
| +12% | +$246K | 0.01% | 1392 |
|
|
2018
Q4 | $1.67M | Buy |
615,462
+352,830
| +134% | +$1.16M | 0.01% | 1336 |
|
|
2018
Q3 | $882K | Buy |
+262,632
| New | +$811K | ﹤0.01% | 2074 |
|
|
2017
Q4 | – | Sell |
-455,720
| Closed | -$1.48M | – | 3547 |
|
|
2017
Q3 | $1.48M | Buy |
455,720
+347,035
| +319% | +$1.07M | 0.01% | 1482 |
|
|
2017
Q2 | $350K | Buy |
+108,685
| New | +$308K | ﹤0.01% | 2558 |
|
|
2016
Q2 | – | Sell |
-39,692
| Closed | -$35K | – | 3350 |
|
|
2016
Q1 | $35K | Sell |
39,692
-18,785
| -32% | -$18.2K | ﹤0.01% | 2729 |
|
|
2015
Q4 | $71K | Buy |
+58,477
| New | +$81.4K | ﹤0.01% | 2600 |
|
|
2013
Q4 | – | Sell |
-49,668
| Closed | -$201K | – | 2445 |
|
|
2013
Q3 | $201K | Buy |
+49,668
| New | +$217K | ﹤0.01% | 1642 |
|
Other funds holding ATRS
Two Sigma Investments's ATRS Position: Q2 2022 in Review
Two Sigma Investments sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 660,601 shares — an estimated $2.71M sold.
Two Sigma Investments first reported a position in ATRS in Q3 2013 and held it in 20 quarters. The position peaked at $9.33M in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Two Sigma Investments reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Two Sigma Investments sold 660,601 Antares Pharma, Inc. shares in Q2 2022, an estimated $2.71M.
- Two Sigma Investments first reported a position in Antares Pharma, Inc. in Q3 2013 and held it in 20 quarters.
- Two Sigma Investments's Antares Pharma, Inc. position peaked at $9.33M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.